Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy

BACKGROUND: Emerging evidence has shown that intra-tumor immune features are associated with response to immune checkpoint blockade (ICB) therapy. Accordingly, patient stratification is needed for identifying target patients and designing strategies to improve the efficacy of ICB therapy. We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingkai, Liu, Qiaofei, Zhang, Xiang, Cui, Ming, Li, Tong, Zhang, Yalu, Liao, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908647/
https://www.ncbi.nlm.nih.gov/pubmed/33637086
http://dx.doi.org/10.1186/s12935-021-01824-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908647/
https://www.ncbi.nlm.nih.gov/pubmed/33637086
http://dx.doi.org/10.1186/s12935-021-01824-z

Ejemplares similares